Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy

Journal of Clinical Oncology

Volumn 14, Issue 2, 1996, Pages 373-381

  Kushner, B H ^a   Cheung, N K ^a   LaQuaglia, M P ^a   Ambros, P F ^a   Ambros, I M ^a   Bonilla, M A ^a   Gerald, W L ^a   Ladanyi, M ^a   Gilbert, F ^a   Rosenfield, N S ^a   Yeh, S D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INVASION; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 9044230125     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.2.373     Document Type: Article

References (71)

1. Bader KL, Miller RW: US cancer incidence and mortality in the first year of life. Am J Dis Child 133:157-159, 1979
2. Miller RW, Young JL, Novakovic B: Childhood Cancer. Cancer 75:395-405, 1995
3. Brodeur GM, Seeger RC, Barrett A, et al: International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 6:1874-1881, 1988
4. Brodeur GM, Pritchard J, Berthold F, et al: Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11:1466-1477, 1993
5. Phillip T, Zucker JM, Bernard JL, et al: Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: Is cure possible in a small subgroup? J Clin Oncol 6:1037-1044, 1991
6. Zucker JM: Retrospective study of 462 neuroblastomas treated between 1950 and 1970. Maandschr Kindergeneesk 42:369-385, 1974
7. Castleberry RP, Crist WM, Cain WS, et al: Management of localized thoracic neuroblastoma. Med Pediatr Oncol 7:153-161, 1979
8. Adam A, Hochholzer L: Ganglioneuroblastoma of the posterior mediastinum: A clinicopathologic review of 80 cases. Cancer 47:373-381, 1981
9. Hayes FA, Green A, Hustu HO, et al: Surgicopathologic staging of neuroblastoma: Prognostic significance of regional lymph node metastases. J Pediatr 102:59-62, 1983
10. Nitschke R, Humphrey GB, Sexauer CL, et al: Neuroblastoma: Therapy for infants with good prognosis. Med Pediatr Oncol 11:154-158, 1983
11. Carachi R, Campbell PE, Kent M: Thoracic neural crest tumors. A clinical review. Cancer 51:949-954, 1983
12. Evans AE, Brand W, de Lorimier A, et al: Results in children with local and regional neuroblastoma managed with and without vincristine, cyclophosphamide, and imidazole-carboxamide. A report from the Children's Cancer Study Group. Am J Clin Oncol 6:3-8, 1984
13. Le Tourneau JN, Bernard JL, Hendren WH, et al: Evaluation of the role of surgery in 130 patients with neuroblastoma. J Pediatr Surg 20:244-249, 1985
14. O'Neill JA, Littman P, Blitzer P, et al: The role of surgery in localized neuroblastoma. J Pediatr Surg 20:708-712, 1985
15. Berthold F, Brandeis WE, Lampert F: Neuroblastoma: Diagnostic advances and therapeutic results in 370 patients. Monogr Paediat 18:206-223, 1986
16. De Bemardi B, Rogers D, Carli M, et al: Localized neuroblastoma. Surgical and pathologic staging. Cancer 60:1066-1072, 1987
17. Nitschke R, Smith EI, Shochat S, et al: Localized neuroblastoma treated by surgery: A Pediatric Oncology Group study. J Clin Oncol 6:1271-1279, 1988
18. Evans AE, D'Angio GJ, Randolph J: A proposed staging for children with neuroblastoma. Cancer 27:374-378, 1971
19. Ninane J, Pritchard J, Jones PMM, et al: Stage II neuroblastoma. Adverse prognostic significance of lymph node involvement. Arch Dis Child 57:438-442, 1982
20. Rosen EM, Cassady JR, Kretschmar C, et al: Influence of local-regional lymph node metastases on prognosis in neuroblastoma. Med Pediatr Oncol 12:260-263, 1984
21. McGuire WA, Simmons D, Grosfeld JL, et al: Stage II neuroblastoma - Does adjuvant irradiation contribute to cure? Med Pediatr Oncol 13:117-121, 1985
22. Matthay KK, Sather HN, Seeger RC, et al: Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol 7:236-244, 1989
23. Nitschke R, Smith EI, Altshuler G, et al: Postoperative treatment of nonmetastatic visible residual neuroblastoma: A Pediatric Oncology Group study. J Clin Oncol 9:1181-1188, 1991
24. Castleberry R, Shuster JJ, Altshuler G, et al: Infants with neuroblastoma and regional lymph node metastases have a favorable outlook after limited postoperative chemotherapy: A Pediatric Oncology Group study. J Clin Oncol 10:1299-1304, 1992
25. Evans AE, Baum E, Chard R: Do infants with stage IV-S neuroblastoma need treatment? Arch Dis Child 56:271-274, 1981
26. Nickerson HJ, Nesbit ME, Grosfeld JL, et al: Comparison of stage IV and IV-S neuroblastoma in the first year of life. Med Pediatr Oncol 13:261-268, 1985
27. Stephenson SR, Cook BA, Mease AD, et al: The prognostic significance of age and pattern of metastases in stage IV-S neuroblastoma. Cancer 58:372-375, 1986
28. Bourhis J, Dominici DH, Raschella G, et al: N-myc genomic content and DNA ploidy in stage IVS neuroblastoma. J Clin Oncol 9:1371-1375, 1991
29. De Bernardi B, Pianca C, Boni L, et al: Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stage. Cancer 70:1625-1633, 1992
30. Kushner BH, Cheung NKV, LaQuaglia MP: Low-risk and moderate-risk neuroblastoma, in Raghavan D, Scher HI, Leibel SA, et al (eds): Principles and Practice of Genitourinary Oncology. Philadelphia, PA, Lippincott, (in press)
31. Seeger RC, Brodeur GM, Sather H, et al: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111-1116, 1985
32. Evans AE, D'Angio GJ, Propert K, et al: Prognostic factors in neuroblastoma. Cancer 59:1853-1859, 1987
33. Hayashi Y, Kanda N, Inaba T, et al: Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer 63:126-132, 1989
34. Fong C, White PS, Peterson K, et al: Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. Cancer Res 52:1780-1785, 1992
35. Look AT, Hayes FA, Nitschke R, et al: Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med 311:231-235, 1984
36. Kaneko Y, Kanda N, Maseki N, et al: Different karyotypic patterns in early and advanced stage neuroblastomas. Cancer Res 47:311-318, 1987
37. Look AT, Hayes FA, Shuster JJ, et al: Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: A Pediatric Oncology Group study. J Clin Oncol 9:581-591, 1991
38. Shimada H, Chatten J, Newton WA Jr, et al: Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73:405-416, 1984
39. Joshi VJ, Cantor AB, Altschuler G, et al: Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas. A clinicopathologic study of 211 cases from the Pediatric Oncology Group. Cancer 69:2197-2211, 1992
40. Brodeur GM: TRK-A expression in neuroblastomas: A new prognostic marker with biological and clinical significance. J Natl Cancer Inst 85:344-345, 1993 (editorial)
41. Reynolds CP, Frenkel EP, Smith RG: Growth characteristics of neuroblastoma in vitro correlate with patient survival. Trans Assoc Am Physicians 93:203-211, 1980
42. Shuster JJ, McWilliams NB, Castleberry R, et al: Serum lactate dehydrogenase in childhood neuroblastoma. Am J Clin Oncol 15:295-303, 1992
43. Zeltzer PM, Marangos PJ, Evans AE, et al: Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course. Cancer 57:1230-1234, 1986
44. Laud W, Siegel S, Shaw KNF, et al: Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma. Pediatrics 62:77-87, 1978
45. Nakagawara A, Sasazuki T, Akiyama H, et al: N-myc oncogene and stage IV-S neuroblastoma. Preliminary observations on ten cases. Cancer 65:1960-1967, 1990
46. Wilson PCG, Coppes MJ, Solh H, et al: Neuroblastoma stage IV-S: A heterogeneous disease. Med Pediatr Oncol 19:467-472, 1991
47. Bourhis J, DeVathaire F, Wilson GD, et al: Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma. Cancer Res 51:33-36, 1991
48. Silber JH, Evans AE, Fridman M: Models to predict outcome from childhood neuroblastoma: The role of serum ferritin and tumor histology. Cancer Res 51:1426-1433, 1991
49. Kushner BH, O'Reilly RJ, LaQuaglia MP, et al: Dose-intensive use of cyclophosphamide in ablation of neuroblastoma. Cancer 66:1095-1100, 1990
50. Kushner BH, LaQuaglia MP, Bonilla MA, et al: Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age. J Clin Oncol 12:2607-2613, 1994
51. Kohl N, Kanda N, Schreck R, et al: Transposition and amplification of oncogene-related sequences in human neuroblastoma. Cell 35:359-367, 1983
52. Heiden T, Wang N, Tribukait B: An improved Hedley method for preparation of paraffin-embedded tissues for flow cytometric analysis of ploidy and S-phase. Cytometry 12:614-621, 1991
53. Stock C, Ambros IM, Mann G, et al: Detection of 1p36 deletions in paraffin sections of neuroblastoma tissues. Genes Chrom Cancer 6:1-9, 1993
54. Bowman L, Castleberry R, Altschuler G, et al: Therapy based on DNA index (DI) for infants with unresectable and disseminated neuroblastoma (NB): The Pediatric Oncology Group "better risk" study. Proc Am Soc Clin Oncol 11:365, 1992 (abstr)
55. Castleberry RP, Kun LE, Shuster JJ, et al: Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma. J Clin Oncol 9:789-795, 1991
56. Tsuchida Y, Yokoyama J, Kaneko, et al: Therapeutic significance of surgery in advanced neuroblastoma: A report from the Study Group of Japan. J Pediatr Surg 27:616-622, 1992
57. West DC, Shamberger RC, Macklis RM, et al: Stage III neuroblastoma over 1 year of age at diagnosis: Improved survival with intensive multimodality therapy including multiple alkylating agents. J Clin Oncol 11:84-90, 1993
58. Garaventa A, De Bernardi B, Pianca C, et al: Localized but unresectable neuroblastoma: Treatment and outcome of 145 cases. J Clin Oncol 11:1770-1779, 1993
59. Castel V, Badal MD, Bezanilla JL, et al: Treatment of stage III neuroblastoma with emphasis on intensive induction chemotherapy: A report from the Neuroblastoma Group of the Spanish Society of Pediatric Oncology. Med Pediatr Oncol 24:29-35, 1995
60. Rubie H, Plantaz D, Michon J, et al: Localized neuroblastoma: N-myc gene amplification is the main prognostic factor and postoperative treatment can be deleted in infants. Med Pediatr Oncol 21:582, 1993 (abstr)
61. Bernstein ML, Azouz EM, Woods W, et al: Persistence and possible progression of a pelvic neuroblastoma detected by mass screening during 19 months. Am J Pediatr Hematol Oncol 16:164-166, 1994
62. Matthay KK, Stram D, Seeger RC, et al: A prospective Childrens Cancer Group study of stage II neuroblastoma treated with surgery alone. Proc Am Soc Clin Oncol 12:414, 1993 (abstr)
63. Felici L, Limiento D, Giorgi PL: Multifocal neuroblastoma. Med Pediatr Oncol 18:231-233, 1990
64. Cohn SL, Herst CV, Maurer HS, et al: N-myc amplification in an infant with stage IVS neuroblastoma. J Clin Oncol 5:1441-1444, 1987
65. Brodeur GM, Hayes FA, Green AA, et al: Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients. Cancer Res 47:4248-4253, 1987
66. Jereb B, Tournade MF, Lemerle J, et al: Lymph node invasion and prognosis in nephroblastoma. Cancer 45:1632-1636, 1980
67. Mandell L, Ghavimi F, LaQuaglia M, et al: Prognostic significance of regional lymph node involvement in childhood extremity rhabdomyosarcoma. Med Pediatr Oncol 18:466-471, 1990
68. Kushner BH, Cheung NKV: Neonatal screening and management of biologically low-risk localized neuroblastoma. Am J Pediatr Hematol Oncol 17:180, 1995 (letter)
69. Strother D, Cantor A, Halperin E, et al: Treatment of Pediatric Oncology Group (POG) stage C neuroblastoma (NBL): A preliminary POG report. Proc Am Soc Clin Oncol 12:415, 1993 (abstr)
70. Brodeur GM, Castleberry RP: Neuroblastoma, in Pizzo PA, Poplack DG (eds): Pediatric Oncology (ed 2). Philadelphia, PA, Lippincott, 1994, pp 739-767
71. Murphy SB, Cohn SL, Craft AW, et al: Do children benefit from mass screening for neuroblastoma? Lancet 337:344-345, 1991